Literature DB >> 11247558

Ischaemic colitis in a patient taking meloxicam.

B Garcia, F Ramaholimihaso, M D Diebold, G Cadiot, G Thiéfin.   

Abstract

The safety of cyclo-oxygenase 2 (COX-2) preferential inhibitors such as meloxicam is debated. We describe a patient who presented with bloody diarrhoea after 15 mg meloxicam daily for 10 days for osteoarthritis. The endoscopic and histological features were consistent with the diagnosis of ischaemic colitis. Symptoms and endoscopic lesions quickly regressed within 1 week of meloxicam withdrawal. There was no evidence of another cause of colonic ischaemia. We suggest that meloxicam might have intestinal toxic effects when taken in high doses, because of reduced COX-2 selectivity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247558     DOI: 10.1016/S0140-6736(00)04141-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  2 in total

1.  The NSAID roller coaster: more about rofecoxib.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-09       Impact factor: 4.335

2.  Risk factors associated with the development of ischemic colitis.

Authors:  Joaquín Cubiella Fernández; Luisa Núñez Calvo; Elvira González Vázquez; Maria Jesús García García; Maria Teresa Alves Pérez; Isabel Martínez Silva; Javier Fernández Seara
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.